Alamar Biosciences, Inc. (California) (ALMR)

30.60 -3.44 (-10.11%) USD  |  NASDAQ  |  Oct 30, 16:00
30.10 -0.50 (-1.63%) Pre-Market: 20:00
More

Alamar Biosciences Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for ALMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2026. Start Trial.
Date Value
October 14, 2026 --
October 13, 2026 --
September 23, 2026 --
September 03, 2026 --
August 11, 2026 --
Date Value
July 16, 2026 --
July 15, 2026 --
July 13, 2026 --
May 12, 2026 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Personalis, Inc. Upgrade
10X Genomics, Inc. Upgrade
Champions Oncology, Inc. Upgrade
Medpace Holdings, Inc. Upgrade
Avantor, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade